“Use of Ketamines in Patients Refractory to Conventional Treatment of MDD”. Research, Society and Development 12, no. 11 (November 7, 2023): e145121143894. Accessed March 3, 2026. https://www.rsdjournal.org/rsd/article/view/43894.